Prostate cancer trials in Spain

87 of 102 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 15 November 2026. Ask the study team whether a trial fits you.

• Phase 1Taking people
  A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma

  Where

  Barcelona, Castello De La Plana, L'Hospitalet de Llobregat, Madrid, Málaga, Pozuelo de Alarcón, Valencia

  Age

  18 years and over

  People

  453 worldwide

  Run by

  Pfizer

  See details and how to joinNCT03460977 · EU 2023-509179-18-00
• Phase 3Taking people
  Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)

  Where

  Jerez de la Frontera, Lugo, Madrid, Ourense, Sevilla, Valencia

  Age

  18 years and over

  People

  1,310 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT06136624 · EU 2023-504899-25-00
• Phase 1/2Taking people
  TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

  Where

  Barcelona, L'hospitalet De Llobregat, Madrid, Majadahonda

  Age

  18 years and over

  People

  181 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT07190300 · EU 2025-521873-15-00
• Phase 1Taking people
  Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

  Where

  Barcelona, Madrid, Pamplona

  Age

  18 years and over

  People

  505 worldwide

  Run by

  Amgen

  See details and how to joinNCT04221542 · EU 2023-504361-23-00
• Phase 1Taking people
  A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

  Where

  Logrono, Madrid, Valencia

  Age

  18 years and over

  People

  150 worldwide

  Run by

  IDEAYA Biosciences

  See details and how to joinNCT07503808 · EU 2026-526299-21-00
• Phase 1/2Taking people
  First-Time-in-Human Study of GSK5471713 in Adults With mCRPC

  Where

  Barcelona, Logroño, Málaga

  Age

  18 years and over

  People

  54 worldwide

  Run by

  GlaxoSmithKline

  See details and how to joinNCT07332455
• Phase 2Taking people
  A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer

  Where

  Barakaldo, Córdoba, L'Hospitalet de Llobregat, Madrid, Valencia

  Age

  18 years and over

  People

  100 worldwide

  Run by

  Hoffmann-La Roche

  See details and how to joinNCT07287150 · EU 2025-521327-67-00
• Phase 3Taking people
  Diagnostic Performance of [18F]PSMA-1007 PET/CT Imaging in Patients With Newly-Diagnosed Prostate Cancer

  Where

  Barcelona, Valencia

  Age

  18 years and over

  People

  434 worldwide

  Run by

  ABX advanced biochemical compounds GmbH

  See details and how to joinNCT06122584
• Phase 1Suspended
  A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

  Where

  L'Hospitalet de Llobregat, Madrid, Sevilla

  Age

  18 years and over

  People

  460 worldwide

  Run by

  Eli Lilly and Company

  See details and how to joinNCT06465069 · EU 2024-512927-36-00
• Phase 1Taking people
  A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring

  Where

  Barcelona, Madrid, Pamplona, Salamanca

  Age

  18 years and over

  People

  120 worldwide

  Run by

  Janssen Research & Development, LLC

  See details and how to joinNCT06788509 · EU 2024-515457-21-00
• Phase 1Not yet taking people in Spain
  A Study of LY4257496 in Participants With Cancer (OMNIRAY)

  Where

  Barcelona, Madrid

  Age

  18 years and over

  People

  421 worldwide

  Run by

  Eli Lilly and Company

  See details and how to joinNCT07114601 · EU 2025-522367-15-00
• Phase 1Taking people
  A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer

  Where

  Barcelona, Madrid, Pamplona

  Age

  18 years and over

  People

  210 worldwide

  Run by

  Genentech, Inc.

  See details and how to joinNCT05800665 · EU 2023-504013-68-00
• Phase 1Taking people
  A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate Cancer

  Where

  Barcelona, Madrid

  Age

  18 years and over

  People

  300 worldwide

  Run by

  Janssen Research & Development, LLC

  See details and how to joinNCT05818683 · EU 2022-503132-14-00
• Phase 3Taking people
  A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)

  Where

  Barcelona, Jerez de la Frontera, Madrid, Málaga

  Age

  18 years and over

  People

  1,203 worldwide

  Run by

  Janssen Research & Development, LLC

  See details and how to joinNCT07164443 · EU 2025-520927-26-00
• Phase 3Taking people
  A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

  Where

  Badalona, Madrid, Murcia, Sevilla, Valencia, Zaragoza

  Age

  18 years and over

  People

  800 worldwide

  Run by

  Janssen Research & Development, LLC

  See details and how to joinNCT07225946 · EU 2025-522713-29-00
• Phase 1Not yet taking people in Spain
  A Study of JNJ-98768111 in Participants With Advanced Prostate Cancer

  Where

  Madrid

  Age

  18 years and over

  People

  160 worldwide

  Run by

  Janssen Research & Development, LLC

  See details and how to joinNCT07746713 · EU 2026-525894-37-00
• Phase 3Active, not recruiting
  A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.

  Where

  L'Hospitalet de Llobregat, Madrid, Valencia

  Age

  18 years and over

  People

  900 worldwide

  Run by

  Pfizer

  See details and how to joinNCT06629779 · EU 2024-511652-40-00
• Phase 3Taking people
  A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

  Where

  Barcelona, Córdoba, Lugo, Madrid, Majadahonda, Pozuelo de Alarcón, Santander, Santiago de Compostela, Sevilla, Valencia

  Age

  18 years and over

  People

  1,440 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT06925737 · EU 2024-517423-40-00
• Phase 1/2Taking people
  EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors

  Where

  Barcelona, Logroño, Madrid, Palma, Zaragoza

  Age

  18 years and over

  People

  160 worldwide

  Run by

  Eikon Therapeutics

  See details and how to joinNCT07262619 · EU 2026-525248-13-00
• Phase 1Not yet taking people in Spain
  Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

  Where

  Barcelona, L'Hospitalet de Llobregat, Madrid

  Age

  18 years to 100 years

  People

  272 worldwide

  Run by

  Janux Therapeutics

  See details and how to joinNCT05519449 · EU 2026-526777-42-00
• Phase 1/2Taking people
  Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors

  Where

  Barcelona, Madrid

  Age

  18 years and over

  People

  205 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT07288359
• Phase 1Taking people
  Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer

  Where

  Barcelona, Logrono, Madrid, Málaga, Murcia, Pamplona, Pozuelo de Alarcón, Sabadell, Valencia

  Age

  18 years and over

  People

  347 worldwide

  Run by

  Astellas Pharma Global Development, Inc.

  See details and how to joinNCT05997615 · EU 2023-503495-24-00
• Phase 2Taking people
  A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

  Where

  Barcelona, Madrid, Málaga, Seville, Valencia

  Age

  18 years and over

  People

  740 worldwide

  Run by

  Daiichi Sankyo

  See details and how to joinNCT06172478 · EU 2023-507641-29-00
• Phase 1Taking people
  A Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)

  Where

  Barcelona, Logroño, Madrid, Pozuelo de Alarcón

  Age

  18 years and over

  People

  60 worldwide

  Run by

  Daiichi Sankyo

  See details and how to joinNCT07244341 · EU 2025-522512-16-00
• Phase 1Taking people
  A clinical trial to learn about the effects of INR731 alone or with an androgen receptor pathway inhibitor (ARPI) in men with prostate cancer

  Where

  Madrid, Valencia

  Age

  18 years and over

  People

  26 worldwide

  Run by

  Novartis Pharma AG

  See details and how to join2025-524080-20-00